In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ashley Yeo

Ashley Yeo is attached to the medtech titles within Informa’s Pharma intelligence division.

As Health Care editor on In Vivo (monthly hardcopy and online daily services), he writes and commissions news and feature material to meet the strategic business and market access information needs of senior players and device makers as they move innovations into the global medtech market place.

As part of the Principal Analyst team, he also contributes news delivery and insight needs across the group’s other medtech titles in the field of market access (global regulatory, reimbursement, policy changes). Key areas of focus are Germany, the UK and global themes, and EU and other outside global regulatory insight.

A linguist by training, he joined what was later to become Informa in mid-1988 as a French and German news reporter (with some other European languages also in the mix), and has been editor of three of the group’s titles (including Clinica) over a 14-year-period.

These duties are combined with supporting the growing Ask The Analyst service. He says: “This helps us as a group keep a close relationship with long-term and potential subscribers in a sector where insight and knowledge are key to our clients’ commercial success.”

Latest From Ashley Yeo

How COVID Boosted Medtech In The Eyes Of The World

Reaching deep and being resourceful were the in-demand attributes that medtech industry leaders brought to bear when the COVID-19 pandemic stretched health care providers almost to breaking point.

Leadership Medical Device

Singapore’s Medtech Thought Leader Role And ASEAN Update

Singapore drives much of the medtech regulatory and policy thought leadership in the ASEAN region, as shown in its regulatory collaboration with Thailand and actions on cybersecurity and packaging waste.

Asia Pacific Regulation

China’s Greater Bay Area Offers Medtech Harmonization Zone For Hong Kong

Medtech businesses in both Hong Kong and mainland China stand to gain from the Guangdong Hong Kong Macao Greater Bay Area plan, according to China’s medtech regulator, the NMPA.

Asia Pacific Hong Kong

Health Care Provider C-Suite Energized By Pandemic Crisis

Royal Philips anticipated a degree of negative sentiment from health system managers about the outlook for innovation and progress in health care delivery when it polled the provider C-suite for its 2021 Future Health Index report. It was surprised by the actual outcome.

Leadership Healthcare Systems

Singapore Consults On Medtech UDI System

Singapore’s devices regulator is seeking comments on recently issued draft guidance on a medical device Unique Device Identification system.

Singapore Asia Pacific

Chinese Medtech Contracting And Liability Changes From 1 June

China has amended its 2014 primary regulation governing medical devices. The new version of the Regulation on Supervision and Administration of Medical Devices comes into force on 1 June, says Todd Liao of Morgan Lewis.

China Regulation
See All
UsernamePublicRestriction

Register